483 related articles for article (PubMed ID: 20655714)
21. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Shen KP; Lin HL; Hsieh SL; Kwan AL; Chen IJ; Wu BN
J Pharm Pharmacol; 2009 Apr; 61(4):517-25. PubMed ID: 19298700
[TBL] [Abstract][Full Text] [Related]
22. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
[TBL] [Abstract][Full Text] [Related]
23. Dietary docosahexaenoic acid-rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J-Lep(ob/ob) mice.
Kim HJ; Lee KT; Park YB; Jeon SM; Choi MS
Mol Nutr Food Res; 2008 Aug; 52(8):965-73. PubMed ID: 18481331
[TBL] [Abstract][Full Text] [Related]
24. Ameliorative effects of black tea extract on aflatoxin-induced lipid peroxidation in the liver of mice.
Choudhary A; Verma RJ
Food Chem Toxicol; 2005 Jan; 43(1):99-104. PubMed ID: 15582201
[TBL] [Abstract][Full Text] [Related]
25. Preventive action of green tea from changes in the liver antioxidant abilities of different aged rats intoxicated with ethanol.
Augustyniak A; Waszkiewicz E; Skrzydlewska E
Nutrition; 2005 Sep; 21(9):925-32. PubMed ID: 16084066
[TBL] [Abstract][Full Text] [Related]
26. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
[TBL] [Abstract][Full Text] [Related]
27. Green tea extract ameliorates reperfusion injury to rat livers after warm ischemia in a dose-dependent manner.
Liang R; Nickkholgh A; Kern M; Schneider H; Benzing S; Zorn M; Büchler MW; Schemmer P
Mol Nutr Food Res; 2011 Jun; 55(6):855-63. PubMed ID: 21595017
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
[TBL] [Abstract][Full Text] [Related]
29. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
[TBL] [Abstract][Full Text] [Related]
30. Green tea catechins, alleviate hepatic lipidemic-oxidative injury in Wistar rats fed an atherogenic diet.
Ramesh E; Jayakumar T; Elanchezhian R; Sakthivel M; Geraldine P; Thomas PA
Chem Biol Interact; 2009 Jun; 180(1):10-9. PubMed ID: 19428341
[TBL] [Abstract][Full Text] [Related]
31. MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.
Ohyama T; Sato K; Yamazaki Y; Hashizume H; Horiguchi N; Kakizaki S; Mori M; Kusano M; Yamada M
World J Gastroenterol; 2014 Nov; 20(43):16227-35. PubMed ID: 25473177
[TBL] [Abstract][Full Text] [Related]
32. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.
Rhee SD; Kim CH; Park JS; Jung WH; Park SB; Kim HY; Bae GH; Kim TJ; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):9-18. PubMed ID: 22742899
[TBL] [Abstract][Full Text] [Related]
33. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
[TBL] [Abstract][Full Text] [Related]
34. Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells.
Vidyashankar S; Sandeep Varma R; Patki PS
Toxicol In Vitro; 2013 Mar; 27(2):945-53. PubMed ID: 23348005
[TBL] [Abstract][Full Text] [Related]
35. Serum ornithine carbamyltransferase reflects hepatic damage in diabetic obese mice.
Murayama H; Ikemoto M; Hamaoki M
J Gastroenterol Hepatol; 2010 Feb; 25(2):413-9. PubMed ID: 19793175
[TBL] [Abstract][Full Text] [Related]
36. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Fiorini RN; Donovan JL; Rodwell D; Evans Z; Cheng G; May HD; Milliken CE; Markowitz JS; Campbell C; Haines JK; Schmidt MG; Chavin KD
Liver Transpl; 2005 Mar; 11(3):298-308. PubMed ID: 15719408
[TBL] [Abstract][Full Text] [Related]
37. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice.
Harada K; Shen WJ; Patel S; Natu V; Wang J; Osuga J; Ishibashi S; Kraemer FB
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1182-95. PubMed ID: 12954598
[TBL] [Abstract][Full Text] [Related]
38. Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis.
Kuo JJ; Chang HH; Tsai TH; Lee TY
Int J Mol Med; 2012 Sep; 30(3):673-9. PubMed ID: 22751848
[TBL] [Abstract][Full Text] [Related]
39. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
Lee MS; Kim CT; Kim Y
Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
[TBL] [Abstract][Full Text] [Related]
40. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
